![168712-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2022-08/168712-Thumbnail%20Image.png?versionId=icWNuNmqRkt8ailen2XKpm3bvmm2KUTm&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T001428Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=138420b19f9c5f6ddb943d89f6c04e48ba7df3078c8beedb8247ac3653f4cc98&itok=JXWzmspC)
![187681-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2023-06/187681-Thumbnail%20Image.png?versionId=EGd3TOn37.Q4DTF9wb7R4Wi4b2a8qQAT&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T203315Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=af5aeea1e21f96a115eb0a74ab6d6739ce1f1ba646f51168ac710b13aa45f85f&itok=70T76ZZi)
Maternal morbidity and mortality rates in the United States continues to rise, with a wide range of contributing factors such as mental illness, cardiovascular disease and systemic inequality. This metastudy provides a holistic view of the research that has been published on the issue of U.S. maternal healthcare from 2000-2022. The patterns of publications on specific topics over time can tell us what is perceived as a current major cause by physicians, public leaders, researchers, and the public. A deeper dive into systemic inequality as a cause of maternal morbidity and mortality highlights it as a major contributor to these high rates, but that progress is slowly being made through the implementation of detection and prevention tactics, as well as accessible prenatal programs and care.
![191701-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2024-03/191701-Thumbnail%20Image.png?versionId=qsz2cSlSsVukYfsD.rYx1hgSHcz8046N&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T005359Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=bcaec715edb5df287cf7c8b4e439d199d334f07fa6005382d5a0d930fa87a6d5&itok=DngEXEPZ)
![157179-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-09/157179-Thumbnail%20Image.png?versionId=Jl4AWnXMJ9kzCHgsxAtZ0fN8YDP3EP05&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T033719Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=c5ad4dc076e71e579a47977e336e0fb9be4316694226ab02fba1f12c0ceb19c5&itok=tq_U69S1)
![153970-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-09/153970-Thumbnail%20Image.png?versionId=POpMu1NBUR5JapNLls40DVaUeZwxeGf_&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T033919Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=49975432b4af315956ad93ee95feba75fa02a530bcd13dcc8a59af9850e39652&itok=pICbC0Mv)
![154503-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-09/154503-Thumbnail%20Image.png?versionId=9lJz8P_xVJuIkv7TDbT04Nq_.gzpyud9&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T202200Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=699cdae2f30ec734a77a33504451d1c3a655eb6e24871cd478ef00ab6858a6c5&itok=hVVeji98)
![152481-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-08/152481-Thumbnail%20Image.png?versionId=bxNBnEGz_NCttrbmUBWonAyARJ_d6fNg&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T035317Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=982064e4b9373839c32b43c8236e60fb2dcda67c7eae7b6ba55f7c493376a9fa&itok=HgENAfOW)
![153737-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-08/153737-Thumbnail%20Image.png?versionId=jbZOdAEIFZyxDWyR6we25LsivjiGUNOH&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T024135Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=81e9854c5a48fbf3b138e2cd407c574eda812ec0d89b65271f16d461776370fd&itok=MextHLde)
Methods: Participants were recruited from the parent REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. ActicalTM accelerometers provided estimates of PA variables, including moderate-to-vigorous PA (MVPA), high light PA (HLPA), low light PA (LLPA) and sedentary time, for 4-7 consecutive days. Prevalence and incidence of cognitive impairment were defined by the Six-Item Screener. Letter fluency, animal fluency, word list learning and Montreal Cognitive Assessment (orientation and recall) were conducted to assess executive function and memory.
Results: Of the 7,339 participants who provided accelerometer wear data > 4 days (70.1 ± 8.6 yr, 54.2% women, 31.7% African American), 320 participants exhibited impaired cognition. In cross-sectional analysis, participants in the highest MVPA% quartile had 39% lower odds of cognitive impairment than those in the lowest quartile (OR: 0.61, 95% C.I.: 0.39-0.95) after full adjustment. Further analysis shows most quartiles of MVPA% and HLPA% were significantly associated with executive function and memory (P<0.01). During 2.7 ± 0.5 years of follow-up, 3,385 participants were included in the longitudinal analysis, with 157 incident cases of cognitive impairment. After adjustments, participants in the highest MVPA% quartile had 51% lower hazards of cognitive impairment (HR: 0.49, 95% C.I.: 0.28-0.86). Additionally, MVPA% was inversely associated with change in memory z-scores (P<0.01), while the highest quartile of HLPA% was inversely associated with change in executive function and memory z-scores (P<0.01).
Conclusion: Higher levels of objectively measured MVPA% were independently associated with lower prevalence and incidence of cognitive impairment, and better memory and executive function in older adults. Higher levels of HLPA% were also independently associated with better memory and executive function. The amount of MVPA associated with lower risk of cognitive impairment (259 min/week) is >70% higher than the minimal amount of MVPA recommended by PA guidelines.
![153092-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-08/153092-Thumbnail%20Image.png?versionId=LCpR7lXgTP2HPmBGkcDw7onbGMry.3dN&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T021144Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=760997b11c716cf6fada90558fb9081f7125e8d291c3b3d0943a35dec122ec17&itok=v_aPUPz-)